Category Archives: Hivefire

3-D imaging confirms volumizing effects of fractional bipolar RF

Breaking News – April 18, 2012

New Method to Reveal Alzheimer’s Marker Shows Promise – Early study uses drug and imaging scans to pinpoint plaques associated with disease

WorldCare Clinical Appoints New Executive Director of Quality & Regulatory Affairs

Lilly wins FDA approval for Alzheimer’s imaging agent

New Lilly drug has small sales potential

The Calendar – PharmaVOICE April 2012

What’s New – PharmaVOICE April 2012

Imaging Trial for Novel Liver Cancer Treatment Shows Promising Results

ACC: Evidence for Coronary CTA in the ED Builds